Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?

In this article, we provide a case-based expert opinion on the duration of extended adjuvant endocrine therapy, use of biomarkers in guiding this decision, and toxicities to be considered when recommending this treatment.